Medicine Research Studies | Medical News, Treatment Articles


FDA Approves New Valsartan Product Following Major Recall

The Food and Drug Administration (FDA) has approved a new generic version of Diovan (Novartis) that does not contain N-nitrosodimethylamine (NDMA) or N-nitrosodiethylamine (NDEA), 2 potentially carcinogenic impurities identified in several recalled valsartan products.
people sitting in a circle at group therapy

Patient-Centered Medical Management for Depression

Researchers found that there has been little attention paid to intervention to enhance treatment adherence in nonpsychotic major depression, so they outlined steps for engagement, retention, and adherence for these patients.
Next post in Medicine